208 participants
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2019-11-07
- Completion:
- 2027-02-26
Conditions
- Multiple Myeloma
Interventions
- DRUG
No Results Yet